Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07045688

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Recruiting

Interested in participating?

Request Info

Key information

Conditions

H. Pylori Infection

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag University Hospital

Sohag, Egypt

Location status: Recruiting

Location contact

Magdy M Amin, Professor

CONTACT

01090801900

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: >18 years old.
  • H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).

Exclusion criteria

  • Prior H. pylori treatment: Previous treatment for H. pylori infection.
  • Allergies: Known allergies to study medications or components.
  • Patients cannot finish treatment course.
  • Patient missed follow up.
  • Patients refusing or neglecting test of cure for H. pylori.

Treatment and study plan

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection

Drug

we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection

Drug

we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

Drug

we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Primary outcomes

  1. efficacy medical treatment for eradication of Helicobacter Pylori infection in naive patient.

    Time frame: 4 weeks after successful medical treatment

    stool antigen for H. Pylori

Study contacts

Contact information is provided by the study sponsor or research team.

Andrew K Wadea, Resident

CONTACT

[email protected]

01211498813

Hamdy S Mohammed, Professor

CONTACT

01111101934

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 1, 2025
Registry last updated
Jul 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.